
TB-500
Thymosin beta-4 fragment studied for cell movement, blood vessels, and tissue repair.
For Research Use Only
Sold strictly for laboratory research. Not for human or veterinary use, ingestion, or clinical/diagnostic application.
The lower price is applied automatically once your cart holds 5 or more of this vial.
Bacteriostatic water included
About this peptide
TB-500 is a laboratory-made fragment based on an active region of thymosin beta-4, a naturally occurring protein involved in tissue maintenance. Researchers study how it affects cell movement, new blood-vessel formation, and inflammatory signalling. Most evidence comes from laboratory and animal tissue-repair models.
Why researchers reach for TB-500
Cell motility
Actin-sequestering behavior referenced in migration assays.
Vascular remodeling
Angiogenesis literature across cardiac and dermal models.
Inflammation resolution
Referenced in cytokine-modulation and fibrosis studies.
Key features
- ≥99% HPLC purity
- Truncated Tβ4 active fragment
- Mass-spec verified
- Cold-chain dispatch
How it works
Actin binding
Reversibly sequesters G-actin monomers to modulate cytoskeletal dynamics.
Endothelial signaling
Upregulates VEGF and related angiogenic markers in vitro.
Anti-fibrotic profile
Reduces TGF-β driven fibrosis in animal cardiac models.
Research dosage guidelines
Reference ranges only — reproduced from published preclinical literature. Not a recommendation for human use.
| Range | Reported dose | Note |
|---|---|---|
| Typical reconstitution | 2 mL bacteriostatic water | Yields 2.5 mg/mL (2500 mcg/mL) |
| Reported research range | 1–5 mg/week (split) | Reference only |
Tracking this compound? Registered researchers can log active TB-500 protocols in their private Research Log.
Timing in research protocols
No published human timing data.
- No human pharmacokinetic or dose-finding trial for TB-500 has been published.
- Native thymosin beta-4 shows a short plasma half-life in early intravenous reports; longer 'tissue half-life' claims for TB-500 are not peer-reviewed.
- Weekly loading-then-maintenance schedules in circulation come from non-clinical sources.
- No credible time-of-day or meal-timing evidence exists.
Drawn from published research protocols and pharmacology literature. Reference information for laboratory research only — not an instruction or guidance for use.
Technical specifications
- Sequence
- Ac-LKKTETQ (Tβ4 17-23 fragment)
- Molecular weight
- 889.05 g/mol
- Purity
- ≥99% (HPLC)
- Form
- Lyophilized powder
- Vial size
- 5 mg
- Storage (lyophilised vial)
- Cool, dry and protected from light
- Storage (after reconstitution)
- 2–8°C
Published research
Peer-reviewed literature on TB-500. Links open in a new tab.
Research use notice
Sold for in vitro laboratory research only. Not for human or veterinary use, diagnosis, or therapy.
